Locus Biosciences Inc., a biotechnology company developing precision antibacterial therapies, announced today that it ha...
HJB and MabSpace Biosciences (MabSpace) today announced that the two companies have entered into a definitive merge...
PolarityTE, Inc., a commercial-stage biotechnology company focused on transforming the lives of patients by discovering,...
Ocular Therapeutix, a biopharmaceutical company focused on the formulation, development, and commercialization of innova...
Sarepta Therapeutics, a leader in precision genetic medicine for rare diseases, granted equity awards on December 31, 20...
Rakuten Aspyrian, a biotechnology company developing precision-targeted cancer therapies based on its proprietary Photoi...
Purdue Research Foundation’s Foundry Investment Fund has invested a total of $750,000 in three life scie...
Xynomic Pharmaceuticals, Inc., a clinical stage US-China oncology drug development company has announced that it has bee...
Phoenix Life Sciences International Limited, an international adaptive healthcare solutions company has announced that M...
The Board of Directors of Prometic Life Sciences Inc. has announced that it has named Prof. Simon Best as Interim Chief ...
Biotech Start-up company, Relay Therapeutics has announced the successful completion of a $400 million Series C financin...
Gritstone Oncology, Inc., a clinical-stage biotechnology company developing the next generation of cancer immunotherapie...
Biopharmaceutical company Alvotech has announced that Japan-based Fuji Pharma has acquired a 4.2% stake in the business ...
Amgen and Molecular Partners, a clinical-stage biotech company pioneering the use of DARPin® therapeutics, have...
Pall Corporation, the global leader of advanced filtration, separation and purification technologies, has established a ...
Erasca, a company dedicated to advancing exceptional scientific approaches to erase cancer, has completed a $42 million ...
DelSiTech Ltd, a Finnish drug delivery technology and drug development company and InnovareR&D, a leading Mexican ph...
IFM Therapeutics (IFM), a privately held biopharmaceutical company focused on developing therapies that modulate novel t...
Staten Biotechnology has signed a dyslipidaemia licence option deal worth US$430 million with Novo Nordisk. Unde...
Singapore - 2019 ENMORE BIO CONFERENE will be held on 1st-3rd, March, 2019 in Nanjing Young Cultural Center, Nanjing, Ch...
Bristol-Myers Squibb Company has announced that the Committee for Medicinal Products for Human Use (CHMP) of the Europea...
Bristol-Myers Squibb Company and Boston Medical centre, a private, not-for-profit, academic medical centre has announced...
Celltrion, Inc. and Teva Pharmaceutical Industries Ltd. have announced that the U.S. Food and Drug Administration (FDA) ...
NeuClone Pharmaceuticals Ltd. (NeuClone), a clinical-stage biopharmaceutical company exclusively focused on developing h...
Cellect Biotechnology Ltd., a developer of a novel stem cell production technology, announced that KORIL-RDF, has approv...
